ID   PI4KB_HUMAN             Reviewed;         816 AA.
AC   Q9UBF8; B4DGI2; O15096; P78405; Q5VWB9; Q5VWC0; Q5VWC1; Q9BWR6;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=Phosphatidylinositol 4-kinase beta;
DE            Short=PI4K-beta;
DE            Short=PI4Kbeta;
DE            Short=PtdIns 4-kinase beta;
DE            EC=2.7.1.67;
DE   AltName: Full=NPIK;
DE   AltName: Full=PI4K92;
GN   Name=PI4KB; Synonyms=PIK4CB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAC51156.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9405935; DOI=10.1093/dnares/4.4.273;
RA   Suzuki K., Hirano H., Okutomi K., Suzuki M., Kuga Y., Fujiwara T.,
RA   Kanemoto N., Isono K., Horie M.;
RT   "Identification and characterization of a novel human
RT   phosphatidylinositol 4-kinase.";
RL   DNA Res. 4:273-280(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain {ECO:0000312|EMBL:BAA21661.1};
RX   PubMed=9405938; DOI=10.1093/dnares/4.4.301;
RA   Saito T., Seki N., Ishii H., Ohira M., Hayashi A., Kozuma S.,
RA   Hori T.-A.;
RT   "Complementary DNA cloning and chromosomal mapping of a novel
RT   phosphatidylinositol kinase gene.";
RL   DNA Res. 4:301-305(1997).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart {ECO:0000269|PubMed:9020160};
RX   PubMed=9020160; DOI=10.1074/jbc.272.7.4384;
RA   Meyers R., Cantley L.C.;
RT   "Cloning and characterization of a wortmannin-sensitive human
RT   phosphatidylinositol 4-kinase.";
RL   J. Biol. Chem. 272:4384-4390(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH00029.1}, and
RC   Testis {ECO:0000312|EMBL:AAH40300.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-118; 121-229; 236-303; 319-442; 497-798 AND
RP   804-816 (ISOFORM 2), CLEAVAGE OF INITATOR METHIONINE, ACETYLATION AT
RP   GLY-2, PHOSPHORYLATION AT SER-294, INTERACTION WITH ACBD3; C10ORF76;
RP   RAB11B; YWHAB; YWHAE; YWHAG; YWHAH; YWHAQ; YWHAZ AND SFN, MUTAGENESIS
RP   OF 40-LEU--VAL-42; 43-ILE--PRO-45; 46-GLU-VAL-47; 49-GLN-LYS-50;
RP   CYS-52; 53-GLN-GLU-54; 55-VAL-LEU-56 AND 57-GLU--VAL-59, AND MASS
RP   SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mBio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L.,
RA   DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially
RT   affected by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9148941; DOI=10.1074/jbc.272.20.13236;
RA   Wong K., Meyers R., Cantley L.C.;
RT   "Subcellular locations of phosphatidylinositol 4-kinase isoforms.";
RL   J. Biol. Chem. 272:13236-13241(1997).
RN   [10]
RP   FUNCTION.
RX   PubMed=10559940; DOI=10.1038/12993;
RA   Godi A., Pertile P., Meyers R., Marra P., Di Tullio G., Iurisci C.,
RA   Luini A., Corda D., De Matteis M.A.;
RT   "ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates
RT   synthesis of PtdIns(4,5)P2 on the Golgi complex.";
RL   Nat. Cell Biol. 1:280-287(1999).
RN   [11]
RP   PHOSPHORYLATION AT SER-258; THR-263; SER-266; SER-277; SER-294;
RP   THR-438; SER-511 AND THR-519.
RX   PubMed=11277933; DOI=10.1046/j.1432-1327.2001.02089.x;
RA   Suer S., Sickmann A., Meyer H.E., Herberg F.W., Heilmeyer L.M.G. Jr.;
RT   "Human phosphatidylinositol 4-kinase isoform PI4K92. Expression of the
RT   recombinant enzyme and determination of multiple phosphorylation
RT   sites.";
RL   Eur. J. Biochem. 268:2099-2106(2001).
RN   [12]
RP   FUNCTION.
RX   PubMed=12749687; DOI=10.1080/1521654031000090896;
RA   Heilmeyer L.M.G. Jr., Vereb G. Jr., Vereb G., Kakuk A., Szivak I.;
RT   "Mammalian phosphatidylinositol 4-kinases.";
RL   IUBMB Life 55:59-65(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   INTERACTION WITH ARF1 AND ARF3, AND SUBCELLULAR LOCATION.
RX   PubMed=17555535; DOI=10.1111/j.1600-0854.2007.00594.x;
RA   Haynes L.P., Sherwood M.W., Dolman N.J., Burgoyne R.D.;
RT   "Specificity, promiscuity and localization of ARF protein interactions
RT   with NCS-1 and phosphatidylinositol-4 kinase-III beta.";
RL   Traffic 8:1080-1092(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-511, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258; SER-277; SER-428
RP   AND SER-511, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294
RP   (ISOFORM 2), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258; SER-266 AND
RP   SER-428, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258; SER-266; SER-277;
RP   SER-428; SER-511 AND THR-517, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Phosphorylates phosphatidylinositol (PI) in the first
CC       committed step in the production of the second messenger inositol-
CC       1,4,5,-trisphosphate (PIP). May regulate Golgi
CC       disintegration/reorganization during mitosis, possibly via its
CC       phosphorylation. Involved in Golgi-to-plasma membrane trafficking
CC       (By similarity). {ECO:0000250, ECO:0000269|PubMed:10559940,
CC       ECO:0000269|PubMed:12749687, ECO:0000269|PubMed:9405935}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol = ADP +
CC       1-phosphatidyl-1D-myo-inositol 4-phosphate.
CC       {ECO:0000269|PubMed:9405935}.
CC   -!- ENZYME REGULATION: Inhibited by wortmannin. Increased kinase
CC       activity upon interaction with NCS1/FREQ (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with ARF1 and ARF3 in the Golgi complex, but
CC       not with ARF4, ARF5 or ARF6 (PubMed:17555535). Interacts with
CC       NCS1/FREQ in a calcium-independent manner. Interacts with
CC       CALN1/CABP8 and CALN2/CABP7; in a calcium-dependent manner; this
CC       interaction competes with NCS1/FREQ binding (By similarity).
CC       Interacts with ACBD3. Interacts with YWHAB, YWHAE, YWHAG, YWHAH,
CC       YWHAQ, YWHAZ and SFN (PubMed:23572552).
CC       {ECO:0000250|UniProtKB:O08561, ECO:0000269|PubMed:17555535,
CC       ECO:0000269|PubMed:23572552}.
CC   -!- INTERACTION:
CC       Q9H3P7:ACBD3; NbExp=4; IntAct=EBI-1053214, EBI-1791792;
CC       P03495:NS (xeno); NbExp=2; IntAct=EBI-1053214, EBI-2548993;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system. Mitochondrion outer
CC       membrane; Peripheral membrane protein. Rough endoplasmic reticulum
CC       membrane; Peripheral membrane protein. Golgi apparatus. Cytoplasm,
CC       perinuclear region. Note=Found in the outer membrane of
CC       mitochondria and membranes of the rough endoplasmic reticulum.
CC       Recruited to the Golgi complex by the small GTPase ARF to
CC       stimulate the synthesis of phosphatidylinositol 4,5-bisphosphate
CC       (PIP2) on the Golgi complex.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:9405935}; Synonyms=NPIK-B
CC       {ECO:0000269|PubMed:9405935};
CC         IsoId=Q9UBF8-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9405935}; Synonyms=NPIK-C
CC       {ECO:0000269|PubMed:9405935};
CC         IsoId=Q9UBF8-2; Sequence=VSP_050627;
CC         Note=Contains a phosphoserine at position 294.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=3;
CC         IsoId=Q9UBF8-3; Sequence=VSP_037133;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in heart,
CC       skeletal muscle, pancreas, testis and ovary. Weakly expressed in
CC       liver. {ECO:0000269|PubMed:9020160, ECO:0000269|PubMed:9405935,
CC       ECO:0000269|PubMed:9405938}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. Type III PI4K
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA21661.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAH70326.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=EAW53450.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ011121; CAA09495.1; -; mRNA.
DR   EMBL; AJ011122; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AJ011123; CAA09496.1; -; mRNA.
DR   EMBL; AB005910; BAA21661.1; ALT_INIT; mRNA.
DR   EMBL; U81802; AAC51156.1; -; mRNA.
DR   EMBL; AK294606; BAG57793.1; -; mRNA.
DR   EMBL; AL391069; CAH70324.1; -; Genomic_DNA.
DR   EMBL; AL391069; CAH70325.1; -; Genomic_DNA.
DR   EMBL; AL391069; CAH70326.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471121; EAW53449.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53450.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC000029; AAH00029.1; -; mRNA.
DR   EMBL; BC040300; AAH40300.1; -; mRNA.
DR   CCDS; CCDS55637.1; -. [Q9UBF8-3]
DR   CCDS; CCDS55638.1; -. [Q9UBF8-2]
DR   CCDS; CCDS81376.1; -. [Q9UBF8-1]
DR   PIR; JC5706; JC5706.
DR   RefSeq; NP_001185702.1; NM_001198773.2. [Q9UBF8-2]
DR   RefSeq; NP_001185703.1; NM_001198774.1. [Q9UBF8-2]
DR   RefSeq; NP_001185704.1; NM_001198775.2. [Q9UBF8-3]
DR   RefSeq; NP_001317650.1; NM_001330721.1. [Q9UBF8-1]
DR   RefSeq; NP_002642.1; NM_002651.3.
DR   RefSeq; XP_016856979.1; XM_017001490.1. [Q9UBF8-1]
DR   RefSeq; XP_016856980.1; XM_017001491.1. [Q9UBF8-1]
DR   RefSeq; XP_016856981.1; XM_017001492.1. [Q9UBF8-2]
DR   UniGene; Hs.632465; -.
DR   PDB; 2N73; NMR; -; B=1-68.
DR   PDB; 4D0L; X-ray; 2.94 A; A/C/E=121-799.
DR   PDB; 4D0M; X-ray; 6.00 A; A/C/G/I/M/O/Q/S/W/Y/c/g=121-799.
DR   PDB; 4WAE; X-ray; 3.32 A; A=128-799.
DR   PDB; 4WAG; X-ray; 3.41 A; A=128-799.
DR   PDB; 5C46; X-ray; 2.65 A; E=121-799.
DR   PDB; 5C4G; X-ray; 3.20 A; E=121-799.
DR   PDB; 5EUQ; X-ray; 3.20 A; E=121-248, E=523-799.
DR   PDB; 5FBL; X-ray; 3.37 A; A=128-799.
DR   PDB; 5FBQ; X-ray; 3.79 A; A=128-799.
DR   PDB; 5FBR; X-ray; 3.28 A; A=128-799.
DR   PDB; 5FBV; X-ray; 3.29 A; A=128-799.
DR   PDB; 5FBW; X-ray; 3.49 A; A=128-799.
DR   PDB; 5LX2; X-ray; 2.58 A; B=292-297.
DR   PDB; 5NAS; X-ray; 2.08 A; C/D=289-297.
DR   PDBsum; 2N73; -.
DR   PDBsum; 4D0L; -.
DR   PDBsum; 4D0M; -.
DR   PDBsum; 4WAE; -.
DR   PDBsum; 4WAG; -.
DR   PDBsum; 5C46; -.
DR   PDBsum; 5C4G; -.
DR   PDBsum; 5EUQ; -.
DR   PDBsum; 5FBL; -.
DR   PDBsum; 5FBQ; -.
DR   PDBsum; 5FBR; -.
DR   PDBsum; 5FBV; -.
DR   PDBsum; 5FBW; -.
DR   PDBsum; 5LX2; -.
DR   PDBsum; 5NAS; -.
DR   ProteinModelPortal; Q9UBF8; -.
DR   SMR; Q9UBF8; -.
DR   BioGrid; 111316; 15.
DR   DIP; DIP-42267N; -.
DR   IntAct; Q9UBF8; 10.
DR   MINT; MINT-1681077; -.
DR   STRING; 9606.ENSP00000271657; -.
DR   BindingDB; Q9UBF8; -.
DR   ChEMBL; CHEMBL3268; -.
DR   GuidetoPHARMACOLOGY; 2149; -.
DR   iPTMnet; Q9UBF8; -.
DR   PhosphoSitePlus; Q9UBF8; -.
DR   BioMuta; PI4KB; -.
DR   DMDM; 38372507; -.
DR   EPD; Q9UBF8; -.
DR   MaxQB; Q9UBF8; -.
DR   PaxDb; Q9UBF8; -.
DR   PeptideAtlas; Q9UBF8; -.
DR   PRIDE; Q9UBF8; -.
DR   DNASU; 5298; -.
DR   Ensembl; ENST00000368872; ENSP00000357866; ENSG00000143393. [Q9UBF8-2]
DR   Ensembl; ENST00000368873; ENSP00000357867; ENSG00000143393. [Q9UBF8-1]
DR   Ensembl; ENST00000368874; ENSP00000357868; ENSG00000143393. [Q9UBF8-2]
DR   Ensembl; ENST00000529142; ENSP00000433149; ENSG00000143393. [Q9UBF8-3]
DR   GeneID; 5298; -.
DR   KEGG; hsa:5298; -.
DR   UCSC; uc001ext.4; human. [Q9UBF8-1]
DR   CTD; 5298; -.
DR   DisGeNET; 5298; -.
DR   GeneCards; PI4KB; -.
DR   H-InvDB; HIX0001056; -.
DR   HGNC; HGNC:8984; PI4KB.
DR   HPA; CAB022071; -.
DR   HPA; HPA006280; -.
DR   HPA; HPA006281; -.
DR   MIM; 602758; gene.
DR   neXtProt; NX_Q9UBF8; -.
DR   OpenTargets; ENSG00000143393; -.
DR   PharmGKB; PA162399420; -.
DR   eggNOG; KOG0903; Eukaryota.
DR   eggNOG; ENOG410XPH3; LUCA.
DR   GeneTree; ENSGT00550000074892; -.
DR   HOVERGEN; HBG053597; -.
DR   InParanoid; Q9UBF8; -.
DR   KO; K19801; -.
DR   PhylomeDB; Q9UBF8; -.
DR   TreeFam; TF102042; -.
DR   BioCyc; MetaCyc:HS07046-MONOMER; -.
DR   BRENDA; 2.7.1.67; 2681.
DR   Reactome; R-HSA-1660514; Synthesis of PIPs at the Golgi membrane.
DR   SIGNOR; Q9UBF8; -.
DR   ChiTaRS; PI4KB; human.
DR   GeneWiki; PI4KB; -.
DR   GenomeRNAi; 5298; -.
DR   PMAP-CutDB; Q9UBF8; -.
DR   PRO; PR:Q9UBF8; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143393; -.
DR   CleanEx; HS_PI4KB; -.
DR   ExpressionAtlas; Q9UBF8; baseline and differential.
DR   Genevisible; Q9UBF8; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; TAS:ProtInc.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030867; C:rough endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004430; F:1-phosphatidylinositol 4-kinase activity; IBA:GO_Central.
DR   GO; GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR015433; PI_Kinase.
DR   InterPro; IPR001263; PInositide-3_kin_accessory_dom.
DR   PANTHER; PTHR10048; PTHR10048; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
DR   PROSITE; PS51545; PIK_HELICAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Endoplasmic reticulum; Golgi apparatus; Kinase; Membrane;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:23572552}.
FT   CHAIN         2    816       Phosphatidylinositol 4-kinase beta.
FT                                /FTId=PRO_0000088829.
FT   DOMAIN       29    242       PIK helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00878}.
FT   DOMAIN      558    765       PI3K/PI4K. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00269, ECO:0000305}.
FT   MOD_RES       2      2       N-acetylglycine.
FT                                {ECO:0000269|PubMed:23572552}.
FT   MOD_RES     258    258       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11277933}.
FT   MOD_RES     263    263       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11277933}.
FT   MOD_RES     266    266       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11277933}.
FT   MOD_RES     275    275       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BKC8}.
FT   MOD_RES     277    277       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11277933}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BKC8}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000269|PubMed:11277933,
FT                                ECO:0000269|PubMed:23572552}.
FT   MOD_RES     428    428       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     438    438       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11277933}.
FT   MOD_RES     511    511       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11277933}.
FT   MOD_RES     517    517       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     519    519       Phosphothreonine.
FT                                {ECO:0000269|PubMed:11277933}.
FT   VAR_SEQ       1    332       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037133.
FT   VAR_SEQ     304    318       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9020160,
FT                                ECO:0000303|PubMed:9405935}.
FT                                /FTId=VSP_050627.
FT   MUTAGEN      40     42       LSV->AAA: Small decrease in C10ORF76-
FT                                binding. No effect on ACBD3-, nor RAB11B-
FT                                binding. {ECO:0000269|PubMed:23572552}.
FT   MUTAGEN      43     45       IDP->AAA: Drastically decreased ACBD3-
FT                                binding. No effect on C10ORF76-, nor
FT                                RAB11B-binding.
FT                                {ECO:0000269|PubMed:23572552}.
FT   MUTAGEN      46     47       EV->AA: No effect on ACBD3-, C10ORF76-,
FT                                nor RAB11B-binding.
FT                                {ECO:0000269|PubMed:23572552}.
FT   MUTAGEN      49     50       QK->AA: No effect on ACBD3-, C10ORF76-,
FT                                nor RAB11B-binding.
FT                                {ECO:0000269|PubMed:23572552}.
FT   MUTAGEN      52     52       C->A: No effect on ACBD3-, C10ORF76-, nor
FT                                RAB11B-binding.
FT                                {ECO:0000269|PubMed:23572552}.
FT   MUTAGEN      53     54       QE->AA: Drastically decreased C10ORF76-
FT                                and RAB11B-binding. 6-fold increase in
FT                                ACBD3-binding.
FT                                {ECO:0000269|PubMed:23572552}.
FT   MUTAGEN      55     56       VL->AA: Drastically decreased ACBD3-
FT                                binding. No effect on C10ORF76-, nor
FT                                RAB11B-binding.
FT                                {ECO:0000269|PubMed:23572552}.
FT   MUTAGEN      57     59       EKV->AAA: No effect on ACBD3-, C10ORF76-,
FT                                nor RAB11B-binding.
FT                                {ECO:0000269|PubMed:23572552}.
FT   CONFLICT    216    216       L -> V (in Ref. 3; AAC51156).
FT                                {ECO:0000305}.
FT   CONFLICT    339    339       L -> V (in Ref. 3; AAC51156).
FT                                {ECO:0000305}.
FT   CONFLICT    340    340       A -> V (in Ref. 3; AAC51156).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       P -> S (in Ref. 3; AAC51156).
FT                                {ECO:0000305}.
FT   CONFLICT    446    446       F -> S (in Ref. 4; BAG57793).
FT                                {ECO:0000305}.
FT   CONFLICT    754    754       M -> L (in Ref. 4; BAG57793).
FT                                {ECO:0000305}.
FT   CONFLICT    796    796       S -> G (in Ref. 4; BAG57793).
FT                                {ECO:0000305}.
FT   HELIX        45     63       {ECO:0000244|PDB:2N73}.
FT   HELIX       129    134       {ECO:0000244|PDB:5C46}.
FT   HELIX       141    150       {ECO:0000244|PDB:5C46}.
FT   HELIX       154    163       {ECO:0000244|PDB:5C46}.
FT   HELIX       164    166       {ECO:0000244|PDB:5C46}.
FT   HELIX       169    173       {ECO:0000244|PDB:5C46}.
FT   HELIX       176    185       {ECO:0000244|PDB:5C46}.
FT   HELIX       188    204       {ECO:0000244|PDB:5C46}.
FT   HELIX       206    218       {ECO:0000244|PDB:5C46}.
FT   HELIX       234    242       {ECO:0000244|PDB:5C46}.
FT   HELIX       308    323       {ECO:0000244|PDB:5C46}.
FT   HELIX       324    326       {ECO:0000244|PDB:5C46}.
FT   HELIX       330    341       {ECO:0000244|PDB:5C46}.
FT   TURN        342    344       {ECO:0000244|PDB:5C46}.
FT   HELIX       345    347       {ECO:0000244|PDB:5C46}.
FT   STRAND      349    351       {ECO:0000244|PDB:5C46}.
FT   STRAND      357    359       {ECO:0000244|PDB:5C46}.
FT   STRAND      361    365       {ECO:0000244|PDB:5C46}.
FT   HELIX       368    370       {ECO:0000244|PDB:5C46}.
FT   STRAND      372    374       {ECO:0000244|PDB:4D0L}.
FT   STRAND      376    380       {ECO:0000244|PDB:4D0L}.
FT   STRAND      382    390       {ECO:0000244|PDB:5C46}.
FT   TURN        394    396       {ECO:0000244|PDB:5C46}.
FT   STRAND      397    405       {ECO:0000244|PDB:4D0L}.
FT   TURN        409    411       {ECO:0000244|PDB:5C4G}.
FT   STRAND      512    514       {ECO:0000244|PDB:4D0L}.
FT   HELIX       522    531       {ECO:0000244|PDB:5C46}.
FT   TURN        534    537       {ECO:0000244|PDB:5C46}.
FT   STRAND      541    549       {ECO:0000244|PDB:5C46}.
FT   HELIX       555    573       {ECO:0000244|PDB:5C46}.
FT   STRAND      585    587       {ECO:0000244|PDB:5C46}.
FT   STRAND      589    591       {ECO:0000244|PDB:5C46}.
FT   STRAND      593    595       {ECO:0000244|PDB:5C4G}.
FT   STRAND      600    602       {ECO:0000244|PDB:4D0L}.
FT   STRAND      604    606       {ECO:0000244|PDB:4D0L}.
FT   STRAND      608    610       {ECO:0000244|PDB:4D0L}.
FT   STRAND      614    618       {ECO:0000244|PDB:5C46}.
FT   HELIX       619    625       {ECO:0000244|PDB:5C46}.
FT   HELIX       630    637       {ECO:0000244|PDB:5C46}.
FT   HELIX       644    652       {ECO:0000244|PDB:5C46}.
FT   TURN        659    661       {ECO:0000244|PDB:5C46}.
FT   STRAND      663    665       {ECO:0000244|PDB:5C46}.
FT   STRAND      670    672       {ECO:0000244|PDB:5C46}.
FT   STRAND      676    680       {ECO:0000244|PDB:4D0L}.
FT   STRAND      685    687       {ECO:0000244|PDB:4D0L}.
FT   HELIX       697    702       {ECO:0000244|PDB:5C46}.
FT   HELIX       709    726       {ECO:0000244|PDB:5C46}.
FT   HELIX       729    740       {ECO:0000244|PDB:5C46}.
FT   HELIX       746    748       {ECO:0000244|PDB:5C46}.
FT   HELIX       753    759       {ECO:0000244|PDB:5C46}.
FT   HELIX       761    763       {ECO:0000244|PDB:4D0L}.
FT   HELIX       767    781       {ECO:0000244|PDB:5C46}.
FT   HELIX       782    798       {ECO:0000244|PDB:4D0L}.
SQ   SEQUENCE   816 AA;  91379 MW;  CAD8791729BB4308 CRC64;
     MGDTVVEPAP LKPTSEPTSG PPGNNGGSLL SVITEGVGEL SVIDPEVAQK ACQEVLEKVK
     LLHGGVAVSS RGTPLELVNG DGVDSEIRCL DDPPAQIREE EDEMGAAVAS GTAKGARRRR
     QNNSAKQSWL LRLFESKLFD ISMAISYLYN SKEPGVQAYI GNRLFCFRNE DVDFYLPQLL
     NMYIHMDEDV GDAIKPYIVH RCRQSINFSL QCALLLGAYS SDMHISTQRH SRGTKLRKLI
     LSDELKPAHR KRELPSLSPA PDTGLSPSKR THQRSKSDAT ASISLSSNLK RTASNPKVEN
     EDEELSSSTE SIDNSFSSPV RLAPEREFIK SLMAIGKRLA TLPTKEQKTQ RLISELSLLN
     HKLPARVWLP TAGFDHHVVR VPHTQAVVLN SKDKAPYLIY VEVLECENFD TTSVPARIPE
     NRIRSTRSVE NLPECGITHE QRAGSFSTVP NYDNDDEAWS VDDIGELQVE LPEVHTNSCD
     NISQFSVDSI TSQESKEPVF IAAGDIRRRL SEQLAHTPTA FKRDPEDPSA VALKEPWQEK
     VRRIREGSPY GHLPNWRLLS VIVKCGDDLR QELLAFQVLK QLQSIWEQER VPLWIKPYKI
     LVISADSGMI EPVVNAVSIH QVKKQSQLSL LDYFLQEHGS YTTEAFLSAQ RNFVQSCAGY
     CLVCYLLQVK DRHNGNILLD AEGHIIHIDF GFILSSSPRN LGFETSAFKL TTEFVDVMGG
     LDGDMFNYYK MLMLQGLIAA RKHMDKVVQI VEIMQQGSQL PCFHGSSTIR NLKERFHMSM
     TEEQLQLLVE QMVDGSMRSI TTKLYDGFQY LTNGIM
//
